RATIONALE: Scopolamine, a nonselective muscarinic receptor antagonist, has been used in experimental animal models of dementia. It has been demonstrated to disrupt performances in a battery of behavioral tests. However, no attempt has been made to determine how scopolamine-treated animals would respond to a series of reward-directed instrumental learning (RDIL) tasks. OBJECTIVES: The present study was designed to investigate the effects of chronic intraperitoneal injection of scopolamine in Wistar rats on RDIL, as well as on the expression of memory-related molecules in the dorsal hippocampus (DH) and cerebral cortex (CCx). METHODS: The effects of the pretraining injection of scopolamine on the acquisition of instrumental response (experiment 1) were first investigated. Then, the effects of post-training manipulation on the maintenance of instrumental response and the responses to changes in contingency degradation and signal discrimination were assessed (experiment 2). Finally, the expression of cyclic AMP response element-binding protein (CREB), phosphorylated CREB, and brain-derived neurotrophic factor in the DH and CCx were examined using Western blotting and enzyme-linked immunosorbent assay. RESULTS: The acquisition of instrumental conditioning is more vulnerable than its maintenance. The 3.0-mg/kg dose of scopolamine rendered rats unable to make adaptive changes in facing contingency degradation and correct responses in signal discrimination tasks. Furthermore, CREB signaling was inactivated by pretraining scopolamine treatment in both the DH and CCx. Nevertheless, this pathway was selectively suppressed by post-training treatment only in the CCx during memory reconsolidation. CONCLUSIONS: The results suggest that scopolamine-induced cognitive deficits on RDIL are related to the distinguishing alteration of CREB signaling in the DH and CCx.
RATIONALE: Scopolamine, a nonselective muscarinic receptor antagonist, has been used in experimental animal models of dementia. It has been demonstrated to disrupt performances in a battery of behavioral tests. However, no attempt has been made to determine how scopolamine-treated animals would respond to a series of reward-directed instrumental learning (RDIL) tasks. OBJECTIVES: The present study was designed to investigate the effects of chronic intraperitoneal injection of scopolamine in Wistar rats on RDIL, as well as on the expression of memory-related molecules in the dorsal hippocampus (DH) and cerebral cortex (CCx). METHODS: The effects of the pretraining injection of scopolamine on the acquisition of instrumental response (experiment 1) were first investigated. Then, the effects of post-training manipulation on the maintenance of instrumental response and the responses to changes in contingency degradation and signal discrimination were assessed (experiment 2). Finally, the expression of cyclic AMP response element-binding protein (CREB), phosphorylated CREB, and brain-derived neurotrophic factor in the DH and CCx were examined using Western blotting and enzyme-linked immunosorbent assay. RESULTS: The acquisition of instrumental conditioning is more vulnerable than its maintenance. The 3.0-mg/kg dose of scopolamine rendered rats unable to make adaptive changes in facing contingency degradation and correct responses in signal discrimination tasks. Furthermore, CREB signaling was inactivated by pretraining scopolamine treatment in both the DH and CCx. Nevertheless, this pathway was selectively suppressed by post-training treatment only in the CCx during memory reconsolidation. CONCLUSIONS: The results suggest that scopolamine-induced cognitive deficits on RDIL are related to the distinguishing alteration of CREB signaling in the DH and CCx.
Authors: Dorothy Tse; Rosamund F Langston; Masaki Kakeyama; Ingrid Bethus; Patrick A Spooner; Emma R Wood; Menno P Witter; Richard G M Morris Journal: Science Date: 2007-04-06 Impact factor: 47.728
Authors: Hyeon Yong Lee; Jin Bae Weon; Youn Sik Jung; Nam Young Kim; Myong Ki Kim; Choong Je Ma Journal: Evid Based Complement Alternat Med Date: 2016-04-30 Impact factor: 2.629
Authors: Jae-Chul Lee; Joon Ha Park; Ji Hyeon Ahn; Jinseu Park; In Hye Kim; Jeong Hwi Cho; Bich Na Shin; Tae-Kyeong Lee; Hyunjung Kim; Minah Song; Geum-Sil Cho; Dae Won Kim; Il Jun Kang; Young-Myeong Kim; Moo-Ho Won; Soo Young Choi Journal: Mol Med Rep Date: 2017-11-15 Impact factor: 2.952
Authors: Jae-Chul Lee; In Hye Kim; Jeong Hwi Cho; Tae-Kyeong Lee; Joon Ha Park; Ji Hyeon Ahn; Bich Na Shin; Bing Chun Yan; Jong-Dai Kim; Yong Hwan Jeon; Young Joo Lee; Moo-Ho Won; Il Jun Kang Journal: Mol Med Rep Date: 2018-01-09 Impact factor: 2.952